Angioid streaks represent a very subtle clinical entity with a potential of causing significant vision loss. Choroidal neovascular membrane (CNVM) involving the macula followed by streaks extending subfoveally have been described as the most common causes of vision loss.\[[@ref1]\] Anti-vascular endothelial growth factor (VEGF) injections are currently the treatment of choice for angioid streak CNVM.\[[@ref2]\] Thermal laser has been described as an effective treatment modality for the treatment of extrafoveal CNVM of varied etiologies including angioid streaks.\[[@ref3]\] We herein describe a case of angioid streak-associated extrafoveal CNVM treated with focal laser, which demonstrated exacerbation of the CNVM post-laser, using optical coherence tomography angiography (OCTA).

Case Report {#sec1-2}
===========

A 64-year-old male patient presented with gradual painless diminution of vision in his right eye for the past 2 years. He was previously diagnosed as right eye wet age-related macular degeneration and was treated with four intravitreal anti-VEGF injections 2 years back. Left eye was asymptomatic and had undergone a cataract surgery 1 year back. He was a known hypertensive under oral medications for the past 10 years.

Best-corrected visual acuity (BCVA) in his right eye was counting fingers at 1 m while left eye had a BCVA of 20/20. Fundus examination revealed a scarred CNVM in his right eye and a small peripapillary subretinal hemorrhage with a dry macula in his left eye \[[Fig. 1a](#F1){ref-type="fig"}\] along with angioid streaks in both eyes. Fundus fluorescein angiography (FFA) and indocyanine green angiography (ICG) were suggestive of the presence of CNVM in the left eye \[Fig. [1b](#F1){ref-type="fig"} and [c](#F1){ref-type="fig"}\]. OCTA revealed a very subtle complex in the deep retinal segmentation corresponding to the leakage on FA in the left eye \[[Fig. 1d](#F1){ref-type="fig"}\] without any subretinal fluid under the fovea on cross-sectional scan \[[Fig. 1e](#F1){ref-type="fig"}\]. Considering the extrafoveal location of the CNVM, an OCTA-guided focal laser was planned for in the left eye. A 532 nm focal laser was done with a spot size of 100 μ, 200 mJ power, and 200 ms duration. One month post-laser, BCVA in the left eye was 20/20, the subretinal hemorrhage had resolved and a regression of the CNVM complex (in the deep retinal segmentation) was noted on OCTA \[[Fig. 1f](#F1){ref-type="fig"}\].

![Fundus photograph of the left eye (a) showing small peripapillary subretinal hemorrhage (black arrow). Fundus fluorescein angiography and indocyanine green angiography (b and c) suggestive of the presence of a choroidal neovascular membrane (white arrow). Optical coherence tomography angiography (d) shows a subtle vascular network (white arrowhead) in the deep retinal segmentation. Optical coherence tomography cross-section (e) showed no subretinal fluid at the macula. One month postlaser, regression of the choroidal neovascular membrane complex was noted on optical coherence tomography angiography (f)](IJO-66-463-g001){#F1}

At 3-month follow-up, the BCVA in the left eye had reduced to 20/30 with a marked increase in the subretinal hemorrhage surrounding a dirty gray membrane located between the disc and macula with activity on OCT \[Fig. [2a](#F2){ref-type="fig"} and [b](#F2){ref-type="fig"}\]. FFA confirmed the presence of an active classic CNVM which was larger in size compared to baseline \[Fig. [3a](#F3){ref-type="fig"}--[c](#F3){ref-type="fig"}\]. OCTA showed an increased CNV network in the deep retinal and choriocapillaris segmentation \[[Fig. 2c](#F2){ref-type="fig"}\]. We noted a post-laser worsening of the angioid streak-associated CNVM and advised intravitreal ziv-aflibercept (IVZ) injection (1.25 mg in 0.05 ml). One month post-intravitreal injection, the left eye showed scarring of the CNVM with minimal residual intraretinal fluid and no subretinal fluid \[Fig. [2d](#F2){ref-type="fig"} and [e](#F2){ref-type="fig"}, [4a](#F4){ref-type="fig"}\]. After the second IVZ injection, he was maintaining visual acuity of 20/20 with no activity on cross-sectional scan \[[Fig. 2f](#F2){ref-type="fig"} and [4b](#F4){ref-type="fig"}\]. Over the next 3 months, the patient maintained a visual acuity of 20/20 but OCT demonstrated the presence of intraretinal fluid \[Fig. [4c](#F4){ref-type="fig"}--[e](#F4){ref-type="fig"}\] and he received the third and fourth IVZ injections accordingly. The patient is scheduled to follow up one month after the fourth IVZ injection.

![Fundus photograph at 3-month follow-up (a) showing a large dirty gray membrane surrounded by subretinal hemorrhage (black arrows) with activity on optical coherence tomography cross-section (b). Optical coherence tomography angiography (c) showing a prominent neovascular network in the deep retinal segmentation. One month post-intravitreal injection, fundus photograph (d) shows scarring while the optical coherence tomography (e) shows minimal intraretinal fluid. Optical coherence tomography after the second intravitreal injection (f) shows a scarred choroidal neovascular membrane with no activity](IJO-66-463-g002){#F2}

![Fundus fluorescein angiography (a-late venous phase, b-recirculation phase, c-late phase) performed at 3-month follow-up, confirming the presence of an active classic choroidal neovascular membrane and demonstrating worsening of the choroidal neovascular membrane compared to baseline](IJO-66-463-g003){#F3}

![Serial monthly optical coherence tomography images starting from the 4^th^ month (a) to the 8^th^ month (e). Scans b-d represent the 5^th^, 6^th^ and 7^th^ month OCT respectively. The patient has a received a total of four ziv-aflibercept injections in the course of his treatment](IJO-66-463-g004){#F4}

Discussion {#sec1-3}
==========

Histologically, angioid streaks represent breaks at the level of the elastic lamina of the Bruch\'s membrane (BM) with associated calcification.\[[@ref4]\] The overlying retinal pigment epithelium as well as the underlying choriocapillaris also show associated degeneration.\[[@ref5]\] Electron microscopy of the streaks confirms a degenerative pathology with the presence of granulomatous material in the elastic lamina of the BM. The altered nature of the elastic lamina and its brittleness explains the worsening of the CNVM post-laser in our case. Modalities such as thermal laser and photodynamic therapy may further damage the brittle BM and enlarge the openings in the BM leading to enlargement of CNVM. Furthermore, the ensuing scarring post-laser may encroach onto the macula contributing to vision loss.\[[@ref6]\]

Thermal laser has been used as a modality for the treatment of angioid streak-associated extrafoveal CNVM. Singerman and Hatem in their series on laser treatment for extrafoveal CNVM associated with angioid streaks, demonstrated that the treated eyes had either retained or improved visual acuity in comparison to the untreated eyes which invariably lost vision. They also added that careful case selection and an indefinite follow-up to look for recurrences are essential in thermal laser-treated cases.\[[@ref7]\] Gelisken *et al*., in a larger series of eyes with longer follow-up, concluded similarly that the laser-treated eyes fared better in comparison to the untreated eyes.\[[@ref3]\] Lim *et al*. stated that thermal laser results in closure of CNVM and stabilization of visual acuity. They also looked at the status of the fellow eyes and concluded that the recurrence rates and visual outcomes were better when the fellow eye had no CNVM or disciform scarring.\[[@ref8]\]

Conclusion {#sec1-4}
==========

In our case, the presence of CNVM on OCTA instigated us to treat the extrafoveal CNV in spite of minimum leakage on FFA. Therefore, understanding of the underlying degenerative pathology in angioid streaks is warranted during the management of associated CNVM. Anti-VEGF injections represent a safe treatment modality with lower incidence of untoward side effects such as exacerbation of the CNVM.
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